verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: fresenius kabi usa, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler fresenius kabi usa, llc
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

verapamil hydrochloride 2.5 mg/mL

Manufacturer
FRESENIUS KABI USA, LLC

Identifiers & Regulatory

Product NDC 65219-384
Product ID 65219-384_f3bdbd6b-0e61-43d3-8016-3edd69bedd38
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA216471
Listing Expiration 2026-12-31
Marketing Start 2024-11-25

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 65219384
Hyphenated Format 65219-384

Supplemental Identifiers

RxCUI
1665057
UPC
0365219384014
UNII
V3888OEY5R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA216471 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/mL
source: ndc
Packaging
  • 25 VIAL, SINGLE-DOSE in 1 CARTON (65219-384-02) / 2 mL in 1 VIAL, SINGLE-DOSE (65219-384-01)
source: ndc

Packages (1)

65219-384-02 25 VIAL, SINGLE-DOSE in 1 CARTON (65219-384-02) / 2 mL in 1 VIAL, SINGLE-DOSE (65219-384-01)

Ingredients (1)

verapamil hydrochloride (2.5 mg/mL)

Linked Drug Pages (1)

Verapamil Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "f3bdbd6b-0e61-43d3-8016-3edd69bedd38", "openfda": {"upc": ["0365219384014"], "unii": ["V3888OEY5R"], "rxcui": ["1665057"], "spl_set_id": ["38ca9270-5538-467a-a3e9-c27968f3aafe"], "manufacturer_name": ["FRESENIUS KABI USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (65219-384-02)  / 2 mL in 1 VIAL, SINGLE-DOSE (65219-384-01)", "package_ndc": "65219-384-02", "marketing_start_date": "20241125"}], "brand_name": "Verapamil Hydrochloride", "product_id": "65219-384_f3bdbd6b-0e61-43d3-8016-3edd69bedd38", "dosage_form": "INJECTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "65219-384", "generic_name": "Verapamil Hydrochloride", "labeler_name": "FRESENIUS KABI USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA216471", "marketing_category": "ANDA", "marketing_start_date": "20241125", "listing_expiration_date": "20261231"}